vs
FIRST INDUSTRIAL REALTY TRUST INC(FR)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是FIRST INDUSTRIAL REALTY TRUST INC的1.0倍($197.9M vs $194.8M),FIRST INDUSTRIAL REALTY TRUST INC净利率更高(75.9% vs 6.7%,领先69.2%),REPLIGEN CORP同比增速更快(13.6% vs 10.0%),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 8.9%)
该企业是一家房地产投资信托机构,主要投资华盛顿大都会区郊区的工业地产与商务园区类资产,拥有成熟的不动产投资运营经验,于2017年被政府物业收入信托正式收购。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
FR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.0倍
$194.8M
营收增速更快
RGEN
高出3.6%
10.0%
净利率更高
FR
高出69.2%
6.7%
两年增速更快
RGEN
近两年复合增速
8.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $194.8M | $197.9M |
| 净利润 | $147.9M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 75.9% | 6.7% |
| 营收同比 | 10.0% | 13.6% |
| 净利润同比 | 179.7% | 143.9% |
| 每股收益(稀释后) | $1.08 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FR
RGEN
| Q1 26 | $194.8M | — | ||
| Q4 25 | $188.4M | $197.9M | ||
| Q3 25 | $181.4M | $188.8M | ||
| Q2 25 | $180.2M | $182.4M | ||
| Q1 25 | $177.1M | $169.2M | ||
| Q4 24 | $175.6M | $174.1M | ||
| Q3 24 | $167.6M | $154.9M | ||
| Q2 24 | $164.1M | $154.1M |
净利润
FR
RGEN
| Q1 26 | $147.9M | — | ||
| Q4 25 | $78.8M | $13.3M | ||
| Q3 25 | $65.3M | $14.9M | ||
| Q2 25 | $55.2M | $14.9M | ||
| Q1 25 | $48.1M | $5.8M | ||
| Q4 24 | $68.4M | $-30.3M | ||
| Q3 24 | $99.4M | $-654.0K | ||
| Q2 24 | $51.3M | $3.3M |
毛利率
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | 34.6% | 9.0% | ||
| Q3 25 | 37.0% | 8.9% | ||
| Q2 25 | 31.7% | 7.6% | ||
| Q1 25 | 31.2% | 3.9% | ||
| Q4 24 | 40.1% | -17.7% | ||
| Q3 24 | 62.6% | -5.1% | ||
| Q2 24 | 31.8% | 1.0% |
净利率
FR
RGEN
| Q1 26 | 75.9% | — | ||
| Q4 25 | 41.8% | 6.7% | ||
| Q3 25 | 36.0% | 7.9% | ||
| Q2 25 | 30.6% | 8.2% | ||
| Q1 25 | 27.2% | 3.4% | ||
| Q4 24 | 39.0% | -17.4% | ||
| Q3 24 | 59.3% | -0.4% | ||
| Q2 24 | 31.3% | 2.2% |
每股收益(稀释后)
FR
RGEN
| Q1 26 | $1.08 | — | ||
| Q4 25 | $0.60 | $0.24 | ||
| Q3 25 | $0.49 | $0.26 | ||
| Q2 25 | $0.42 | $0.26 | ||
| Q1 25 | $0.36 | $0.10 | ||
| Q4 24 | $0.51 | $-0.55 | ||
| Q3 24 | $0.75 | $-0.01 | ||
| Q2 24 | $0.39 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.9B | $2.1B |
| 总资产 | $5.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | $78.0M | $767.6M | ||
| Q3 25 | $33.5M | $748.7M | ||
| Q2 25 | $34.9M | $708.9M | ||
| Q1 25 | $35.7M | $697.2M | ||
| Q4 24 | $44.5M | $757.4M | ||
| Q3 24 | $47.1M | $784.0M | ||
| Q2 24 | $38.5M | $809.1M |
总债务
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
FR
RGEN
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.7B | $2.1B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.7B | $2.0B | ||
| Q4 24 | $2.7B | $2.0B | ||
| Q3 24 | $2.6B | $2.0B | ||
| Q2 24 | $2.6B | $2.0B |
总资产
FR
RGEN
| Q1 26 | $5.8B | — | ||
| Q4 25 | $5.7B | $2.9B | ||
| Q3 25 | $5.5B | $2.9B | ||
| Q2 25 | $5.5B | $2.9B | ||
| Q1 25 | $5.4B | $2.9B | ||
| Q4 24 | $5.3B | $2.8B | ||
| Q3 24 | $5.2B | $2.8B | ||
| Q2 24 | $5.2B | $2.9B |
负债/权益比
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势,按日历期对齐
经营现金流
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | $461.3M | $25.7M | ||
| Q3 25 | $124.6M | $48.1M | ||
| Q2 25 | $126.1M | $28.6M | ||
| Q1 25 | $88.6M | $15.0M | ||
| Q4 24 | $352.5M | $39.2M | ||
| Q3 24 | $105.5M | $49.3M | ||
| Q2 24 | $107.7M | $42.2M |
自由现金流
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率
FR
RGEN
| Q1 26 | — | — | ||
| Q4 25 | 5.85× | 1.93× | ||
| Q3 25 | 1.91× | 3.23× | ||
| Q2 25 | 2.28× | 1.92× | ||
| Q1 25 | 1.84× | 2.57× | ||
| Q4 24 | 5.15× | — | ||
| Q3 24 | 1.06× | — | ||
| Q2 24 | 2.10× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图